ARTICLE | Company News
Elan sells Myobloc to Solstice
July 7, 2004 7:00 AM UTC
ELN sold the worldwide rights for Myobloc/ Neurobloc to Solstice Neurosciences. Myobloc is an injectable solution of botulinum toxin Type B approved in the U.S., Canada and Europe to treat cervical dy...